The safety of phosphodiesterase type 5 inhibitors for erectile dysfunction.
about
Innovative trends and perspectives for erectile dysfunction treatment: A systematic reviewA systematic review on cell seeded tissue engineering of penile corpora.Direct comparison of tadalafil with sildenafil for the treatment of erectile dysfunction: a systematic review and meta-analysis.PDE5 inhibition eliminates cancer stem cells via induction of PKA signaling.Use of phosphodiesterase type 5 inhibitors and risk of melanoma: a meta-analysis of observational studies.
P2860
The safety of phosphodiesterase type 5 inhibitors for erectile dysfunction.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
The safety of phosphodiesterase type 5 inhibitors for erectile dysfunction.
@en
type
label
The safety of phosphodiesterase type 5 inhibitors for erectile dysfunction.
@en
prefLabel
The safety of phosphodiesterase type 5 inhibitors for erectile dysfunction.
@en
P2860
P50
P1476
The safety of phosphodiesterase type 5 inhibitors for erectile dysfunction.
@en
P2093
Francesco Montorsi
P2860
P304
P356
10.1517/14740338.2016.1131818
P407
P577
2016-01-09T00:00:00Z